Search Results 1481-1490 of 39850 for oral

  1. Publications - Jonathan Fillmore, M.D., D.M.D. - Mayo Clinic

    Treatment of temporomandibular joint ankylosis with total prosthetic joint reconstruction: a case series and scoping review of the literature Frontiers of Oral ...

  2. Study Evaluating The Safety And Efficacy Of Fenfluramine Hydrochloride Oral Solution (ZX008)as Adjunctive Therapy In Children With Intractable Epilepsy With Myoclonic-Atonic Seizures - Mayo Clinic

    Study Evaluating The Safety And Efficacy Of Fenfluramine Hydrochloride Oral Solution (ZX008)as Adjunctive Therapy In Children With Intractable Epilepsy With ...

  3. Nylidrin (oral route) - Side effects & dosage - Mayo Clinic

    For oral dosage form (tablets):. Adults: 3 to 12 milligrams (mg) three or four times a day. Missed Dose. If you miss a dose of this medicine, take it as soon ...

  4. A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Hematological Malignancies - Mayo Clinic

    The study will evaluate oral daily administration of eFT508. Treatment and study subject evaluation will be performed in 21-day cycles. Participation ...

  5. Danicopan (oral route) - Side effects & dosage - Mayo Clinic

    For oral dosage form (tablet):. For extravascular hemolysis (EVH):. Adults—At first, 150 milligrams (mg) 3 times a day. Your doctor may adjust your dose as ...

  6. Ruxolitinib Phosphate (Oral JAK Inhibitor INCB18424) in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma - Mayo Clinic

    This phase II trial studies how well giving ruxolitinib phosphate (oral JAK inhibitor INCB18424) works in treating patients with relapsed or refractory diffuse ...

  7. Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects with Recurrence of Clostridium difficile Infection - Mayo Clinic

    Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects with Recurrence of Clostridium difficile Infection · More about research at Mayo Clinic.

  8. Once-daily Oral VT-464 in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone. - Mayo Clinic

    Once-daily Oral VT-464 in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone. · More about research at Mayo Clinic.

  9. Levamisole (oral route) - Side effects & dosage - Mayo Clinic

    Levamisole is used with another cancer medicine (fluorouracil) to help make it work better against cancer of the colon. Levamisole is available only with your ...

  10. Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia or Lobular Carcinoma In Situ - Mayo Clinic

    The purpose of this study is to analyze breast tissue changes after a short course of Tamoxifen (Tam). Participation eligibility. Participant eligibility ...